The secure online e-prescribing portal is available to healthcare providers in the US, interested in a clinically validated, peer reviewed, non-pharmacologic alternative to narcotic and NSAID pain medications
Patients with schizophrenia were administered a higher dose than had been evaluated in any OMS824 trial, which resulted in approximately 50% higher plasma concentrations than did the previously
In this collaboration, NeoStem will sponsor research in the laboratory of principal investigator Dr Michael Young, director of the Ocular Regenerative Medicine Institute at Massachusetts Eye and Ear
In recent years, the new cancer cases and fatalities have been increasing sharply around the world, with China bearing the heaviest toll of this increase. The latest edition
The loan funds will be used to support Lymphoseek commercialization activities, advance the company’s clinical pipeline, accelerate certain development programs, repay certain of the company’s existing outstanding indebtedness
Debiopharm Research & Manufacturing boasts 35 years of expertise in drug development including chemical synthesis, formulation improvement and manufacturing. Major investments have been made since 2007 to automate
This action is being taken because of a pharmacist report that one bottle of Pfizer’s Effexor XR contained one capsule of Tikosyn (dofetilide) 0.25mg in addition to the
The patent covers the use of sd-rxRNAs targeting CTGF, including RXI-109, for the treatment of fibrotic disorders. US patent number 8,664,189, will expire in 2029. The notice of
In the initial term of the agreement Metabolon will carry out small molecule analysis of 10,000 subjects and collaborate with HLI to map changes in the small molecules
The region most affected is Bangalore and North Carolina, particularly in the areas of biostatistics and statistical programming, following the award of large functional service provision (FSP) contracts
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.